Search

Search Results
Results 41 - 50 of 230 for parkinson
  • Health - 28 May 2023
    Movement disorders commonly affect normal fluency, speed and ease of movements and gait. Most of them are cause due to faulty genes that may or may not be inherited.
  • Health - 24 Sep 2022
    Spinocerebellar ataxia (SCA) is a degenerative disease caused by atrophy to the cerebellum, the part of the brain responsible for coordination of movement. Parkinsonism is a clinical syndrome...
  • Health - 16 Nov 2018
    Movement disorders are neurological conditions that characteristically affect the speed, fluency, quality, and ease of voluntary muscle movements. These may affect activities of daily living (ADL), or...
  • Health - 30 Dec 2022
    Lesioning surgery is a procedure that involves purposefully damaging select areas of the brain, to help in the management of a health condition, such as Parkinson’s disease. There are several types...
  • Health - 7 Apr 2023
    Progressive supranuclear palsy (PSP) is a rare brain disorder that affects approximately 6 in 100,000 people worldwide. It is a rare disease that may appear similar to some other neurodegenerative...
  • Health - 7 Apr 2023
    Progressive supranuclear palsy (PSP) was distinguished from Parkinson’s disease in 1963 as the “Steele-Richardson-Olszewski syndrome”. It is a progressive condition that usually shows onset around the...
  • Health - 22 Jul 2023
    Deep brain stimulation (DBS) is a surgical procedure that involves the implantation of a brain pacemaker that delivers electrical impulses to certain parts of the brain.
  • Health - 3 Jan 2023
    Neurology is a branch of medical science that is concerned with disorders and diseases of the nervous system. The term neurology comes from a combination of two words - "neuron" meaning nerve and...
  • Health - 26 Nov 2022
    Deep brain stimulation (DBS) is a neurosurgical procedure that may be used in the treatment and management of some health conditions.
  • Health - 27 Feb 2019
    People with multiple system atrophy (MSA) generally have a very poor prognosis. Their median survival is 6.2 to 9.5 years after the first symptoms appear. Patients who are older at the time of onset...

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.